268 related articles for article (PubMed ID: 14722462)
21. Loteprednol etabonate in the treatment of allergic conjunctivitis: a meta-analysis.
Wu LQ; Chen X; Lou H; Cheng JW; Wei RL
Curr Med Res Opin; 2015 Aug; 31(8):1509-18. PubMed ID: 26039179
[TBL] [Abstract][Full Text] [Related]
22. Management of seasonal allergic conjunctivitis: guide to therapy.
Bielory BP; O'Brien TP; Bielory L
Acta Ophthalmol; 2012 Aug; 90(5):399-407. PubMed ID: 22067457
[TBL] [Abstract][Full Text] [Related]
23. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit.
Krug N; Hohlfeld JM; Geldmacher H; Larbig M; Heermann R; Lavallee N; Nguyen DT; Petzold U; Hermann R
Allergy; 2005 Mar; 60(3):354-9. PubMed ID: 15679722
[TBL] [Abstract][Full Text] [Related]
24. Loteprednol etabonate: a review of ophthalmic clinical studies.
Howes JF
Pharmazie; 2000 Mar; 55(3):178-83. PubMed ID: 10756536
[TBL] [Abstract][Full Text] [Related]
25. Possibilities in improvement of glucocorticoid treatments in asthma with special reference to loteprednol etabonate.
Szelenyi I; Hermann R; Petzold U; Pahl A; Hochhaus G
Pharmazie; 2004 May; 59(5):409-11. PubMed ID: 15212311
[TBL] [Abstract][Full Text] [Related]
26. Topical loteprednol etabonate 0.5 % for treatment of vernal keratoconjunctivitis: efficacy and safety.
Oner V; Türkcü FM; Taş M; Alakuş MF; Işcan Y
Jpn J Ophthalmol; 2012 Jul; 56(4):312-8. PubMed ID: 22622345
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of loteprednol etabonate for treatment of papillae in contact lens-associated giant papillary conjunctivitis.
Bartlett JD; Howes JF; Ghormley NR; Amos JF; Laibovitz R; Horwitz B
Curr Eye Res; 1993 Apr; 12(4):313-21. PubMed ID: 8319490
[TBL] [Abstract][Full Text] [Related]
28. Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.
Sheppard JD; Comstock TL; Cavet ME
Adv Ther; 2016 Apr; 33(4):532-52. PubMed ID: 26984315
[TBL] [Abstract][Full Text] [Related]
29. Treatment of seasonal allergic conjunctivitis with ophthalmic corticosteroids: in search of the perfect ocular corticosteroids in the treatment of allergic conjunctivitis.
Bielory BP; Perez VL; Bielory L
Curr Opin Allergy Clin Immunol; 2010 Oct; 10(5):469-77. PubMed ID: 20720489
[TBL] [Abstract][Full Text] [Related]
30. Emedastine and allergic conjunctivitis: new preparation. Poor assessment.
Prescrire Int; 2001 Apr; 10(52):39-40. PubMed ID: 11718155
[TBL] [Abstract][Full Text] [Related]
31. Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group.
Am J Ophthalmol; 1999 May; 127(5):537-44. PubMed ID: 10334346
[TBL] [Abstract][Full Text] [Related]
32. Double-masked, placebo-controlled evaluation of loteprednol etabonate 0.5% for postoperative inflammation. Loteprednol Etabonate Post-operative Inflammation Study Group 1.
Stewart R; Horwitz B; Howes J; Novack GD; Hart K
J Cataract Refract Surg; 1998 Nov; 24(11):1480-9. PubMed ID: 9818338
[TBL] [Abstract][Full Text] [Related]
33. Compared topical ocular olopatadine 0.1% (Patanol) and loteprednol etabonate 0.2% (Alrex) in an allergen challenge model.
Novack GD
Clin Ther; 2002 Sep; 24(9):1477-8; author reply 1478-80. PubMed ID: 12380639
[No Abstract] [Full Text] [Related]
34. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
Avunduk AM; Tekelioglu Y; Turk A; Akyol N
Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
[TBL] [Abstract][Full Text] [Related]
35. Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty: Prospective Randomized Trial.
Price MO; Feng MT; Scanameo A; Price FW
Cornea; 2015 Aug; 34(8):853-8. PubMed ID: 26020827
[TBL] [Abstract][Full Text] [Related]
36. Loteprednol etabonate: clinical potential in the management of ocular inflammation.
Noble S; Goa KL
BioDrugs; 1998 Oct; 10(4):329-39. PubMed ID: 18020605
[TBL] [Abstract][Full Text] [Related]
37. [Efficacy of nedocromil sodium in perennial allergic conjunctivitis].
Pacor ML; Biasi D; Carletto A; Corrocher R; Lunardi C
Recenti Prog Med; 1998 Oct; 89(10):501-3. PubMed ID: 9842252
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population.
Abelson MB; Ferzola NJ; McWhirter CL; Crampton HJ
Pediatr Allergy Immunol; 2004 Dec; 15(6):551-7. PubMed ID: 15610370
[TBL] [Abstract][Full Text] [Related]
39. [Study on the treatment of dry eye with Loteprednol Etabonate].
Wan PX; Wang XR; Song YY; Li ZY; Duan HC; Zhang W; Liu Z; Wang ZC
Zhonghua Yan Ke Za Zhi; 2012 Feb; 48(2):142-7. PubMed ID: 22490950
[TBL] [Abstract][Full Text] [Related]
40. Effects of topical loteprednol etabonate on tear cytokines and clinical outcomes in moderate and severe meibomian gland dysfunction: randomized clinical trial.
Lee H; Chung B; Kim KS; Seo KY; Choi BJ; Kim TI
Am J Ophthalmol; 2014 Dec; 158(6):1172-1183.e1. PubMed ID: 25128594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
